At present, the US FDA-approved CRC screening methods mainly include colonoscopy, fecal DNA testing, the fecal occult blood test (FOBT), the conventional blood carcinoembryonic antigen (CEA) indicator, and the circulating methylated SEPT9 test. Here, CEACAM5 is linked to colorectal carcinoma.